Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-05-23
1997-11-11
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 4, 514866, 530324, A61K 3816, A61K 3828, C07K 1400
Patent
active
056864116
ABSTRACT:
Agonist analogues of amylin and related pharmaceutical compositions, and methods of treatment of diabetes and other insulin-requiring states, as well as methods of treatment of hypoglycemia, are provided.
REFERENCES:
patent: 5124314 (1992-06-01), Cooper
patent: 5175145 (1992-12-01), Cooper
patent: 5367052 (1994-11-01), Cooper et al.
Clark, A., et al., Lancet ii: 231-234 (1987).
Cooper, G.J.S., et al.. Proc. Natl. Acad. Sci. (USA) 84:8628-8632 (1987).
Cooper G.J.S., et al., in Diabetes 1988, ed. Larkins, R., Zimmet, P. & Chisholm, D. (Elsevier, Amsterdam), pp. 493-496 (1989).
Glenner et al., Biochem. Biophys. Res Commun. 155:608-614 (1988).
Westermark et al., Proc. Natl. Acad. Sci. (USA) 87: 5036-5040 (1990).
Dayhoff et al., "Atlas of Protein Sequence and Structure", vol. 5 pp. 89-99, 1972.
Goodman & Gilman, "The Pharmacological Basis of Therapeutics" 6th Ed. pp. 1514-1519, 1980.
O'Brien, et al., Islet Amyloid Polypeptide and Insulin Secretion From Isolated Perfused Pancreas of Fed, Fasted, Glucose-Treated, and Dexamethasone-Treated Rats, Diabetes 40: 1701-1706 (1991).
Doherty, Endogenous Vasoactive Peptides, Annual Reports In Medicinal Chemistry 26: 83-92 (1991).
Ohagi, et al., Sequences of Islet Amyloid Polypeptide Precursors of An Old-World Monkey, The Pig-Tailed Macaque (Macaca-nemestrina), and The Dog (Canis familiaris), Diabetologia 34: 555-558 (1991).
Gustavsson, et al., Normal Transthyretin And Synthetic Transthyretin Fragments Form Amyloid-Like Fibrils In Vitro, Biochem. Biophys. Res. Commun. 175: 1159-1164 (1991).
Bell, Molecular Defects In Diabetes-Mellitus, Diabetes 40: 413-422 (1991).
Johnson, et al., Newly Identified Pancreatic Protein Islet Amyloid Polypeptide-What Is Its Relationship To Diabetes?, Diabetes 40: 310-314 (1991).
Steiner, et al., Is Islet Amyloid Polypeptide A Significant Factor In Pathogenesis Or Pathophysiology of Diabetes?, Diabetes 40: 305-309 (1991).
Johnson, et al., Amyloid In The Pancreatic-Islets of The Cougar (Felis-concolor) Is Derived From Islet Amyloid Polypeptide (IAPP), Comp. Biochem. Physiol. 98: 115-119 (1991).
Porte, Beta Cells In Type II Diabetes Mellitus, Diabetes 40: 166-180 (1991).
Stridsberg and Wilander, Islet Amyloid Polypeptide (IAPP)-A Short Review, Acta Oncologica 30: 451-456 (1991).
Hilbich, et al., Aggregation and Secondary Structure of Synthetic Amyloid Beta-A4 Peptides of Alzheimer's Disease, J. Mol. Bio. 218: 149-163 (1991).
Albrecht Elisabeth
Gaeta Laura S. L.
Jones Howard
Amylin Pharmaceuticals Inc.
Celsa Bennett
Tsang Cecilia J.
LandOfFree
Amylin agonist peptides and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amylin agonist peptides and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amylin agonist peptides and uses therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1229096